1. Panobinostat: first global approval;Garnock-Jones;Drugs,2015
2. Panobinostat for the treatment of multiple myeloma;Neri;Expert Opin. Investig. Drugs,2012
3. Panobinostat for the management of multiple myeloma;Sivaraj;Future Oncol.,2017
4. Novartis receives FDA approval of Farydak, the first HDAC inhibitor for patients with multiple myeloma;Raedler;Am. Health Drug Benefits,2016
5. Farydak (panobinostat capsules): US prescribing information,2015